What are the side effects of nifedipine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nifedipine Side Effects

Nifedipine's most common side effects include peripheral edema (dose-related, occurring in 18-29% of patients), hypotension, headache, flushing, and dizziness, with immediate-release formulations carrying significantly higher risks of serious cardiovascular complications including increased mortality in coronary artery disease patients. 1, 2

Common Side Effects by Formulation

All Nifedipine Formulations

  • Peripheral edema is the most frequent adverse effect, occurring in a dose-dependent manner: 18% at 30 mg/day, 22% at 60 mg/day, and 29% at 90 mg/day (compared to 10% with placebo) 2
  • Headache occurs commonly across all formulations 1
  • Flushing is frequently reported 1, 2
  • Dizziness affects many patients 1, 2
  • Nausea can occur 1
  • Constipation is reported 1

Cardiovascular Side Effects

  • Hypotension is a significant concern, particularly with immediate-release formulations 1, 2
  • Reflex tachycardia can occur, especially with dihydropyridines 1
  • Increased mortality risk with immediate-release nifedipine in coronary artery disease patients, showing a dose-response relationship: doses of 80 mg/day carry a risk ratio of 2.83 (95% CI 1.35-5.93) for total mortality 3

Critical Safety Concerns

Immediate-Release Nifedipine

Immediate-release nifedipine should be avoided except with concomitant beta-blockade due to increased risk of hypotension and heart failure. 1

  • The European Society of Cardiology explicitly recommends avoiding immediate-release nifedipine in elderly patients (≥75 years) because of hypotension and heart failure risk 1
  • Studies in coronary artery disease patients showed increased serious events when administered early without beta-blocker coverage 1
  • Short-acting nifedipine can cause uncontrolled hypotension, particularly when combined with magnesium sulfate in pregnancy, resulting in fetal compromise 1

Severe Adverse Events (Overdose/High Doses)

  • Profound hypotension requiring cardiovascular support 2, 4, 5
  • Loss of consciousness 2
  • Cardiogenic shock with pulmonary edema 2
  • Heart rhythm disturbances 2
  • Metabolic acidosis and hypoxia 2

Population-Specific Considerations

Elderly Patients

  • Greater antihypertensive effects due to decreased baroreceptor response and age-related increase in drug exposure 1
  • Falls are a significant risk due to hypotension 1
  • Blood pressure monitoring is essential 1

Pregnancy

  • Generally well-tolerated with minimal side effects (5% experiencing flushing or headache) 4, 6
  • Severe maternal hypotension can occur, requiring close vital sign monitoring 4
  • Preferred over immediate-release formulations; extended-release nifedipine is first-line for chronic hypertension in pregnancy 1
  • Side effects may include headaches, tachycardia, or edema 1

Coronary Artery Disease Patients

  • Proischemic effects can occur 3
  • Negative inotropic effects may worsen heart failure 3
  • Prohemorrhagic effects attributed to antiplatelet and vasodilatory actions 3
  • Possible proarrhythmic effects 3

Less Common Side Effects (≤3% incidence)

  • Chest pain, leg pain 2
  • Paresthesia, vertigo 2
  • Rash 2
  • Leg cramps 2
  • Epistaxis, rhinitis 2
  • Impotence, urinary frequency 2

Rare but Serious Side Effects (<1% incidence)

  • Allergic hepatitis 2
  • Anaphylactic reaction 2
  • Stevens-Johnson syndrome 2
  • Toxic epidermal necrolysis 2
  • Gingival hyperplasia 2
  • Transient blindness at peak plasma levels 2
  • Thrombocytopenia, leukopenia 2
  • Exfoliative dermatitis 2

Clinical Monitoring Recommendations

  • Blood pressure monitoring is essential, particularly during initiation 1
  • In critically ill patients, 27% experienced clinically significant hypotension (≥15% SBP reduction or vasopressor requirement) within 1 hour of administration 5
  • Monitor for peripheral edema development, which may lead to traumatic ulcers if misdiagnosed as chronic venous insufficiency 7
  • Discontinuation of nifedipine typically results in resolution of edema-related complications within months 7

Related Questions

Is Procardia 10 mg (nifedipine) contraindicated in a 75‑year‑old patient?
Can Procardia (nifedipine) 20 mg be used safely as a tocolytic in a patient with a blood pressure of 115/74 mm Hg?
What tocolytic should be given to a patient with mild aortic stenosis at 30 weeks of gestation?
What are the recommendations for managing a 36-year-old female, gravida 4, para 2, at 31 weeks gestation, with preeclampsia (PEC), currently on Nifedipine (generic name: Nifedipine) 30 mg daily and Labetalol (generic name: Labetalol) 300 mg orally every 8 hours, with an average blood pressure of 140/80 mmHg, and a plan to increase Nifedipine to 20 mg every 12 hours?
What is the recommended adjustment for antihypertensive therapy in preeclampsia?
Is the detection of Enterococcus faecalis group D at 2,000 CFU/mL in a semen sample likely to represent contamination rather than infection?
What is the recommended management of postpartum hypertension, including treatment thresholds, first‑line oral therapy, severe hypertension treatment, monitoring, and follow‑up?
What preoperative pulmonary assessment and optimization are required for a patient with rheumatoid arthritis-associated interstitial lung disease before elective surgery?
In a man with recurrent bacterial prostatitis primarily due to Escherichia coli, is a low‑level Enterococcus faecalis isolate in semen clinically significant, or should other etiologies be pursued?
What is the recommended empiric antibiotic regimen and overall management for adult infective endocarditis, including native and prosthetic valve scenarios?
What is phage therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.